Policies and Procedures: Difference between revisions

Jump to navigation Jump to search
no edit summary
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 108: Line 108:
|11/01/06
|11/01/06
|07/26/21
|07/26/21
|03/10/23
|07/09/24
|-
|-
|[[Political Activities]]
|[[Political Activities]]
Line 408: Line 408:
|8000
|8000
|11/01/06
|11/01/06
|02/28/23
|07/09/24
|02/28/23
|07/09/24
|-
|-
|[[Compliance Hotline]]
|[[Compliance Hotline]]
Line 415: Line 415:
|08/10/06
|08/10/06
|07/10/23
|07/10/23
|07/10/23
|07/09/24
|-
|-
|[[Inspections/Investigations by Third Parties]]
|[[Inspections/Investigations by Third Parties]]
Line 421: Line 421:
|10/16/04
|10/16/04
|01/20/23
|01/20/23
|01/20/23
|07/09/24
|-
|-
|[[Research Integrity]]
|[[Research Integrity]]
Line 427: Line 427:
|02/11/05
|02/11/05
|08/18/21
|08/18/21
|07/11/23
|07/09/24
|-
|-
|[[Export Control]]
|[[Export Control]]
Line 433: Line 433:
|12/18/12
|12/18/12
|07/21/23
|07/21/23
|07/21/23
|07/09/24
|-
|-
|[[Code of Conduct]]
|[[Code of Conduct]]
|8006
|8006
|03/13/09
|03/13/09
|07/21/23
|07/09/24
|07/21/23
|07/09/24
|-
|-
|[[Use of Human Anatomical Material]]
|[[Use of Human Anatomical Material]]
Line 445: Line 445:
|08/10/05
|08/10/05
|04/05/24
|04/05/24
|04/26/24
|07/09/24
|-
|-
|[[Clinical Research and Clinical Trial Professional and Technical Fee Billing]]
|[[Clinical Research and Clinical Trial Professional and Technical Fee Billing]]
|8008
|8008
|08/23/18
|08/23/18
|
|07/09/24
|07/21/23
|07/09/24
|-
|-
|[[Contracts]]
|[[Contracts]]
|8009
|8009
|11/01/06
|11/01/06
|07/21/23
|07/09/24
|07/21/23
|07/09/24
|-
|-
|[[Conflict of Interest]]
|[[Conflict of Interest]]
Line 463: Line 463:
|09/04/07
|09/04/07
|06/27/23
|06/27/23
|06/27/23
|07/09/24
|-
|-
|[[Red Flag Identity Theft Prevention Program]]
|[[Red Flag Identity Theft Prevention Program]]
|8011
|8011
|01/13/10
|01/13/10
|08/18/21
|07/09/24
|07/21/23
|07/09/24
|-
|-
|[[Principles of Financial Stewardship]]
|[[Principles of Financial Stewardship]]
Line 475: Line 475:
|08/01/10
|08/01/10
|07/21/23
|07/21/23
|07/21/23
|07/09/24
|-
|-
|[[Human Tissue Use and Transfer]]
|[[Human Tissue Use and Transfer]]
Line 481: Line 481:
|03/15/12
|03/15/12
|07/21/23
|07/21/23
|07/21/23
|07/09/24
|-
|-
|[[Disclosing Foreign Support and International Activities]]
|[[Disclosing Foreign Support and International Activities]]
|8014
|8014
|06/26/15
|06/26/15
|07/24/23
|07/09/24
|07/24/23
|07/09/24
|-
|-
|[[Health Care Vendor Interactions]]
|[[Health Care Vendor Interactions]]
Line 493: Line 493:
|08/31/15
|08/31/15
|09/01/20  
|09/01/20  
|03/10/23
|07/09/24
|-
|-
|[[Credit Hour Definition]]
|[[Credit Hour Definition]]
Line 505: Line 505:
|04/11/19
|04/11/19
|04/11/19
|04/11/19
|07/21/23
|07/09/24
|-
|-
|[[Electronic Digital Signatures and Records]]
|[[Electronic Digital Signatures and Records]]
Line 511: Line 511:
|08/14/23
|08/14/23
|09/13/23
|09/13/23
|09/13/23
|07/09/24
|-
|-
|<big>'''Privacy and Information Security Policies'''</big>
|<big>'''Privacy and Information Security Policies'''</big>

Navigation menu